Followers | 496 |
Posts | 29259 |
Boards Moderated | 4 |
Alias Born | 06/17/2010 |
Saturday, April 15, 2017 6:30:46 PM
http://quote.morningstar.com/stock-filing/Annual-Report/2016/12/31/t.aspx?t=:FUTL&ft=10-K&d=1c2d4684b250d8db55b1e39a11afe0b6
DILUTION CONTINUES!
NOTE 6: CONVERTIBLE DEBENTURES AND NOTES
At December 31, 2016 and 2015, the Company had convertible debt consisting of the following:
December 31,
2016
December 31,
2015
Convertible debt $ 425,385 $ 155,000
Plus: put premium 0 5 5,000
Less: debt discount (146,724 ) (87,250 )
Convertible debt, net $ 278,661 $ 105,706
Convertible debt principal payments of $12,500 were in default on maturity date as of December 31, 2016 as of the issuance date of these consolidated financial statements.
FUTURELAND, CORP. AND SUBSIDIARIES
(FORMERLY AEGEA, INC.)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2016 AND 2015
NOTE 6: CONVERTIBLE DEBENTURES AND NOTES (continued)
On October 05, 2015, the Company issued a debenture for $55,000 for a cash advances during October 2015.
The debenture accrues interest at 10% per annum and will convert into the company’s common stock at 45% of the
lowest closing bid price 20 days before the conversion date. The Holder is restricted from any conversions that
would result in the Holder owning over 9.9% of the outstanding common shares of the Company after the conversion.
On November 25, 2015, the Company issued a debenture for $100,000 for a cash advances during November 2015.
The debenture accrues interest at 10% per annum and will convert into the company’s common stock at 45% of the
lowest closing bid price 20 days before the conversion date. The Holder is restricted from any conversions that
would result in the Holder owning over 9.9% of the outstanding common shares of the Company after the conversion.
On January 04, 2016, the Company issued a debenture for $30,000 for a cash advances during January 2016.
The debenture accrues interest at 10% per annum and will convert into the company’s common stock at 50% of the
lowest closing bid price 20 days before the conversion date. The Holder is restricted from any conversions that
would result in the Holder owning over 9.9% of the outstanding common shares of the Company after the conversion.
On January 07, 2016, the Company registered 6,000,000 shares of common stock under form S8 with SEC for employee and consultant compensation.
On January 28, 2016, the Company issued a debenture for $93,750 for a cash advances during January 2016.
The debenture accrues interest at 10% per annum and will convert into the company’s common stock at 50% of the
lowest closing bid price 20 days before the conversion date. The Holder is restricted from any conversions that
would result in the Holder owning over 9.9% of the outstanding common shares of the Company after the conversion.
On February 16, 2016, the Company issued a debenture for $80,000 for a cash advances during February 2016.
The debenture accrues interest at 8% per annum and will convert into the company’s common stock at 50% of the
lowest closing bid price 20 days before the conversion date. The Holder is restricted from any conversions that
would result in the Holder owning over 9.9% of the outstanding common shares of the Company after the conversion.
On April 07, 2016, the Company issued a debenture for $30,000 for an advanced fee on an equity line of credit for $1,000,000. The debenture accrues interest at 8% per annum and will convert into the company’s common stock at 50% of the lowest closing bid price 20 days before the conversion date. The Holder is restricted from any conversions that would result in the Holder owning over 9.9% of the outstanding common shares of the Company after the conversion.
A HUNDRED YEARS FROM NOW IT WILL NOT MATTER WHAT MY BANK ACCOUNT WAS, THE SORT OF HOUSE I LIVED IN, OR THE KIND OF CAR I DROVE...BUT THE WORLD MAY BE DIFFERENT BECAUSE I WAS IMPORTANT IN THE LIFE OF A CHILD.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM